Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection. | Front Immunol | 2021 | 33763060 | PubTator, text mining | PubMed |
| Neurogenic Heterotopic Ossifications Recapitulate Hematopoietic Stem Cell Niche Development Within an Adult Osteogenic Muscle Environment. | Front Cell Dev Biol | 2021 | 33748104 | PubTator, text mining | PubMed |
| Translational research on Myology and Mobility Medicine: 2021 semi-virtual PDM3 from Thermae of Euganean Hills, May 26 - 29, 2021. | Eur J Transl Myol | 2021 | 33733717 | PubTator, text mining | PubMed |
| In Silico Analysis to Identify Molecular Targets for Chemicals of Concern: The Case Study of Flocoumafen, an Anticoagulant Pesticide. | Environ Toxicol Chem | 2021 | 33729601 | PubTator, text mining | PubMed |
| Updates on Genes and Genetic Mechanisms Implicated in Primary Angle-Closure Glaucoma. | Appl Clin Genet | 2021 | 33727852 | PubTator, text mining | PubMed |
| FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening. | J Chem Inf Model | 2021 | 33724022 | PubTator, text mining | PubMed |
| Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis. | AIMS Neurosci | 2021 | 33709028 | PubTator, text mining | PubMed |
| Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva. | JCI Insight | 2021 | 33705358 | PubTator, text mining | PubMed |
| Common genetic variants with fetal effects on birth weight are enriched for proximity to genes implicated in rare developmental disorders. | Hum Mol Genet | 2021 | 33682876 | PubTator, text mining | PubMed |
| MicroRNAs Modulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells. | Int J Mol Sci | 2021 | 33673409 | PubTator, text mining | PubMed |
| Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology. | Cancers (Basel) | 2021 | 33673104 | PubTator, text mining | PubMed |
| Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments. | Cells | 2021 | 33671024 | PubTator, text mining | PubMed |
| Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva. | Biomedicines | 2021 | 33669809 | PubTator, text mining | PubMed |
| Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report. | Medicine (Baltimore) | 2021 | 33655926 | PubTator, text mining | PubMed |
| TGF-β-Induced Endothelial to Mesenchymal Transition Is Determined by a Balance Between SNAIL and ID Factors. | Front Cell Dev Biol | 2021 | 33644053 | PubTator, text mining | PubMed |
| Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition. | Sci Adv | 2021 | 33627422 | PubTator, text mining | PubMed |
| The BMP2 Signaling Axis Promotes Invasive Differentiation of Human Trophoblasts. | Front Cell Dev Biol | 2021 | 33614644 | PubTator, text mining | PubMed |
| Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva. | Bioorg Med Chem Lett | 2021 | 33609658 | PubTator, text mining | PubMed |
| Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling. | Eur J Med Chem | 2021 | 33601309 | PubTator, text mining | PubMed |
| Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. | Mol Ther | 2021 | 33601054 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=51